425: Vireo Growth Eyes Expansion with Planet 13 Merger

Vireo Growth Inc. presents an investor update detailing substantial Q2 2026 financial growth, strategic acquisitions, and a proposed merger with Planet 13 Holdings Inc. to create a leading U.S. cannabis operator.

Summary

• Vireo Growth Inc. reported strong Q2 2026 financial results, with GAAP revenue of $209.3 million, a 335% year-over-year increase, driven by recent mergers and acquisitions.
• The company announced a merger agreement with Planet 13 Holdings Inc., which, if completed, would create one of the largest U.S. cannabis operators by dispensary count (approximately 270) and revenue.
• Proforma revenue for Q2 2026 reached $254.9 million, and annualized proforma revenue is projected at $1.02 billion.
• Adjusted EBITDA (AEBITDA) for Q2 2026 was $41.5 million, a 212% year-over-year increase, with an AEBITDA margin of 19.8%.
• Vireo closed Q2 with $122.7 million in cash and secured a new asset-based revolving credit facility with Bank of Montreal for up to $105 million.
• The company has a robust pipeline with 10 transactions closed since December 2024 and 7 announced and pending, indicating a strong focus on consolidation and integration.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive development, highlighting significant growth and strategic expansion, though tempered by the inherent risks of the cannabis industry and integration challenges.

Positives

• Significant year-over-year revenue growth of 335% in Q2 2026, reaching $209.3 million.
• Substantial increase in Adjusted EBITDA by 212% year-over-year to $41.5 million, with a healthy margin of 19.8%.
• Proforma revenue of $254.9 million in Q2 2026 and an annualized proforma revenue run rate exceeding $1 billion ($1.02B).
• Expansion of operational footprint to 10 states with over 170 dispensary locations, projected to grow to 15 states and over 270 dispensaries post-acquisitions.
• Successful closing of multiple acquisitions (Hawthorne, Eaze, Bridgewell Agribusiness, PharmaCann) and announcement of further strategic deals (Planet 13 merger, C21, Fluent, The Cannabist assets, Ohio transactions).
• Strong liquidity position with $122.7 million in cash at the end of Q2 2026.
• Secured a new $105 million asset-based revolving credit facility with Bank of Montreal, providing financial flexibility at industry-leading rates.
• Demonstrated ability to execute a disciplined acquisition and integration strategy, leading to increased market density and operating leverage.

Negatives

• The presentation relies heavily on proforma and forward-looking statements, which are subject to significant risks and uncertainties.
• Integration of numerous acquisitions presents operational complexities and potential execution risks.
• The cannabis industry is subject to evolving and uncertain regulatory landscapes at federal, state, and local levels.
• The company's financial performance is heavily influenced by the success of its ongoing M&A strategy and the integration of acquired entities.

Risks

• Forward-looking statements are subject to known and unknown risks, uncertainties, and assumptions that could cause actual results to differ materially.
• Potential for adverse outcomes from the proposed merger with Planet 13 Holdings Inc., including failure to obtain regulatory approvals or satisfy closing conditions.
• Risks associated with the timing and content of adult-use legislation in current and future markets.
• Federal, state, local, and foreign government laws and regulations related to cannabis operations, and potential changes to these laws.
• Operational, regulatory, and other risks inherent in the cannabis, agricultural, and manufacturing businesses.
• Liquidity risks and the ability to raise additional financing to continue as a going concern.
• Potential difficulties in forecasting future events and managing growth effectively.
• Risks related to epidemics and pandemics impacting operations and market demand.

Future Outlook

The company anticipates continued acquisitive growth, aiming to become the largest U.S. cannabis operator by dispensary count and revenue. The proforma metrics suggest a significant increase in scale and earnings power. The merger with Planet 13 is a key strategic initiative expected to deepen market presence.

Management Comments

• Vireo combines local cannabis market leadership with a growing agribusiness platform to create scale, improve operating economics and compound shareholder value through disciplined capital allocation.
• The current market conditions create a consolidation opportunity where strong assets are available because operators are balance sheet constrained during a perfect moment of an industry reset.
• We have the balance sheet, an executive team with the expertise, and the vision to execute quickly and take advantage of the window.
• Vireo is successfully implementing a growth strategy where each acquisition strengthens the platform.
• Our competitive advantage is smart, repeatable capital allocation.
• The executive team, led by John Mazarakis and complemented by Tyson Macdonald, is uniquely positioned to capitalize on their vast experiences in operational and institutional investing and lead Vireo Growth in becoming the top cannabis operator in the US.

Industry Context

StockSavvy.ai notes that Vireo's strategy aligns with the broader trend of consolidation within the U.S. cannabis industry, driven by market maturation, improving regulatory environments, and the need for scale to achieve profitability and attract institutional capital. The company's focus on acquiring high-quality, financially constrained assets at attractive valuations is a common strategy among leading consolidators.

Comparison to Industry Standards

• Vireo's proforma revenue run rate of $1.02 billion positions it among the largest multi-state operators (MSOs) in the U.S. cannabis market.
• The target valuation multiple of 4x EBITDA for acquisitions is generally considered attractive in the current M&A landscape for cannabis companies.
• The company's AEBITDA margin of 19.8% is competitive within the industry, though specific comparisons depend on the exact sub-sector and market focus.
• The proposed merger with Planet 13, a significant player in Nevada, aims to create a combined entity with a dispensary network rivaling or exceeding other top MSOs like Curaleaf, Trulieve, and Green Thumb Industries in terms of sheer store count.

Legal Proceedings

• Litigation occurred following Verano's termination of an agreement, which settled in December 2025.

Stakeholder Impact

• Shareholders are expected to benefit from increased scale, potential for improved operating economics, and compounding shareholder value through accretive M&A.
• Employees of acquired companies will be integrated into Vireo's platform, potentially benefiting from expanded opportunities and resources.
• Customers may see improved product availability and potentially more competitive pricing due to increased market density and supply chain efficiencies.
• Suppliers may benefit from Vireo's increased purchasing power and potential for larger, more consistent orders.

Next Steps

• Complete the merger with Planet 13 Holdings Inc., subject to regulatory approvals and stockholder votes.
• Continue to integrate and optimize recently closed acquisitions.
• Pursue further strategic acquisitions to expand market density and platform capabilities.
• File registration statement on Form S-4 with the SEC for the Planet 13 merger.
• Obtain necessary regulatory and third-party approvals for all pending transactions.

Key Dates

Recommendation

The company demonstrates strong growth and a clear strategy for consolidation in a growing industry. However, the heavy reliance on proforma numbers, forward-looking statements, and the inherent risks of the cannabis sector, including regulatory uncertainty and integration challenges, warrant a cautious 'hold' recommendation until the Planet 13 merger is completed and integration progress is more clearly demonstrated.

Keywords

cannabis operator, dispensary network, merger, acquisition, revenue growth, adjusted EBITDA, financial results, consolidation